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Abstract
Background: Error-prone PCR (epPCR) libraries are one of the tools used in directed evolution. The Gateway
®
technology allows constructing epPCR libraries virtually devoid of any background (i.e., of insert-free plasmid), but
requires two steps: the BP and the LR reactions and the associated E. coli cell transformations and plasmid
purifications.
Results: We describe a method for making epPCR libraries in Gateway
® plasmids using an LR reaction without
intermediate BP reaction. We also describe a BP-free and LR-free sub-cloning method for in-frame transferring the
coding sequence of selected clones from the plasmid used to screen the library to another one devoid of tag
used for screening (such as the green fluorescent protein). We report preliminary results of a directed evolution
program using this method.
Conclusions: The one-step method enables producing epPCR libraries of as high complexity and quality as does
the regular, two-step, protocol for half the amount of work. In addition, it contributes to preserve the original
complexity of the epPCR product.
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Background
Gateway
® is an appealing technology because its cloning
efficiency is close to 100% [1]. This feature is particu-
larly welcome when dealing with numerous target genes,
for instance in Structural Genomics. Unfortunately, high
throughput gene expression following gene cloning in
Structural Genomics programs has also revealed that
many recombinant proteins are insoluble in E. coli
thereby precluding their crystallization and their study
by X-ray crystallography. Among the different techni-
ques used to overcome this insolubility problem, one is
directed evolution. The use of directed evolution for
improving recombinant protein solubility can be sum-
marised as follows. A random library of mutants gener-
ated by error-prone PCR (epPCR) and/or DNA shuffling
[2] is screened for variant proteins more soluble than
the wild-type (wt) protein. To that end, the mutated
DNA sequences may be expressed as fusion proteins
with a C-terminal “solubility reporter” such as the green
f l u o r e s c e n tp r o t e i n( G F P )[ 3]. To assess the solubility
gain provided by the mutations, the mutated coding
sequences are then sub-cloned from the solubility repor-
ter expression plasmid to a GFP-free expression plasmid
and the solubility of the tag-free variant is compared to
that of the tag-free wt protein expressed under the same
conditions.
Although the Gateway
® technology is less used in
d i r e c t e de v o l u t i o nt h a ni nS t r u c t u r a lG e n o m i c sp r o -
grams, it has been nevertheless successfully applied in a
directed evolution study that made use of both epPCR
and DNA shuffling [4]. The evolved Tobacco Etch Virus
(TEV) protease exhibited significantly higher solubility
than the wtTEV protease. Incidentally, this study also
revealed a few weak points that seemed to be specifically
associated with the use of the Gateway
® technology
rather than with the screening process or the protein to
evolve. In particular, (i) the number of expression clones
was found to be relatively small, as also reported in
another study [5]; (ii) the generation of epPCR and
DNA shuffling libraries was labor intensive because of
the need for BP and LR reactions to be carried out, and
of the corollary transformations and intermediate
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any medium, provided the original work is properly cited.plasmid medium preparations [6]; (iii) the subcloning of
the coding sequence of selected mutants from the repor-
ter expression plasmid to a non-reporter expression
plasmid was also time-consuming because of the same
requirements.
While the first of the drawbacks listed above can be
easily addressed by transforming expression cells by
electroporation, addressing the other two requires devis-
ing a novel cloning and sub-cloning strategy. With the
specific purpose of overcoming these limitations while
maintaining the obvious advantages of the Gateway
®
technology, we devised a method that allows eliminating
the BP step from the generation of the library and both
the BP and LR steps from the sub-cloning process. We
applied this method to generate a diversity library of the
intrinsically disordered C-terminal domain of the
measles virus nucleoprotein (NTAIL) [7,8] as a first step
towards the dissection of the molecular mechanisms
underlying its interaction with the C-terminal X domain
(XD, aa 459-507) of the viral phosphoprotein [9-17]. A
split-GFP reassembly assay [18-20] was used to screen
the library and to identify clones with novel binding
properties.
Results
1) Generation of an epPCR library
The conventional procedure for generating epPCR
libraries using the Gateway
® technology comprises two
recombination reactions (BP and LR) [4]. We first
addressed the question as to whether each recombina-
tion reaction and associated E. coli cell transformation
decreased the complexity of a given library. A typical
Gateway
® recombination reaction can be described as
the transfer of an insert from a donor to a non-recom-
bined acceptor to yield a recombined acceptor. There-
fore, the library complexity loss can be evaluated by
comparing the number of colonies provided by: (i) a
theoretical experiment made of a 100% efficient LR
reaction (i.e. a reaction where all the non-recombined
acceptor (i.e., Gateway
® plasmid before LR reaction)
molecules are used to yield recombined acceptors (i.e.,
Gateway
® plasmids after LR reaction)) followed by a
100% efficient cell transformation (i.e. a transformation
where all recombined acceptor molecules are uptaken
by cells and where each cell uptakes one recombined
acceptor molecule); (ii) an actual cell transformation by
a recombined acceptor; (iii) an actual cell transforma-
tion by an actual LR reaction using the same donor con-
struct (i.e., the other substrate of the LR reaction) and
the same non-recombined acceptor as in the previous
two instances. The results of this comparison are
reported in Table 1. Since 25 fmoles of acceptor corre-
spond to 1.55 × 10
10 molecules, if the LR reaction and
cell transformation were each 100% efficient, then one
should obtain 1.55 × 10
10 colonies per 25 fmoles of
input acceptor. However, transforming E. coli cells by
electroporation with 25 fmoles of recombined acceptor
provided a mean value of 18.7 × 10
7 colonies. Assuming
that each cell uptakes only one plasmid molecule, this
means that E. coli cells electroporation was responsible
for a ~80-fold drop of the theoretical (maximal) number
of clones in this experiment. In addition, when E. coli
cells were electroporated with an LR reaction mixture
using the same amount of the same acceptor, the aver-
age number of colonies was 2.7 × 10
7 (Table 1). This
means that the recombination reaction was by itself
responsible for an additional ~7 fold efficiency drop.
Incidentally, this latter comparison provided a direct
measure of the efficiency of the LR reaction, which
could be determined to be approximately 14% under the
conditions used in this experiment. In conclusion, each
step made of a recombination reaction followed by
transformation of E. coli by electroporation reduced the
number of clones with respect to what could be
expected from a 100% efficient LR reaction combined
with a 100% efficient cell transformation. Thus, skipping
one recombination reaction and the associated E. coli
transformation in the Gateway
® cloning process would
be expected to better preserve the original library com-
plexity than the classical two step approach (BP followed
by LR), particularly when heat-shock is used instead of
electroporation to transform E. coli cells (Table 1). Inci-
dentally, this would also reduce the risk of biasing the
pENTR library (i.e., the BP reaction product, see stage 1
in the left panel of Figure 1) by unbalanced clone grow-
ing during the culture in the presence of kanamycin. On
the basis of this observation, we devised a new “single
recombination” method for constructing epPCR
libraries.
T h es t r a t e g yw eh a v ed e v i s e di sd e s c r i b e di nF i g u r e1
(right flowchart) and compared to the regular strategy
Table 1 Assessment of the efficiency of E.coli
transformation by different DNA species
Experiment Transforming DNA Number of clones
Theoretical LR reaction 1.55 × 10
10
Electroporation Recombined acceptor
1 18.7 (± 7.2) × 10
7
LR reaction
2 2.7 (± 1.5) × 10
7
Heat shock Recombined acceptor
1 10.8 (± 2.1) × 10
5
LR reaction
2 1.8 (± 0.4) × 10
5
The number of colonies obtained after E. coli transformation by a recombined
acceptor
1, or by an LR reaction
2 is reported. T7pRos E. coli cells were either
electroporated as described in “Methods”, or transformed by heat-shock.
Transformed cells were selected on ACplates. The results are the mean value
and standard deviation of three independent transformations using the same
LR reaction
125 fmoles of pNGG-NTAIL (Table 2).
2using 25 fmoles of non recombined
acceptor plasmid (pNGG, Table 1) and 100 fmoles of linear NTAIL coding
sequence flanked by attL recombination sites (Figure 1, stage 1, right panel)
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Page 2 of 15(left flowchart and reference [4]). It includes not only
the generation of the library (Figure 1, stage 1), but also
the sub-cloning of selected mutant sequences from the
expression plasmid used for screening the random
mutant library (referred to as “reporter expression plas-
mid” throughout the text) to a different expression plas-
mid (referred to as “non-reporter expression plasmid”)
(Figure 1, stage 2) allowing the variant proteins of inter-
est to be expressed without the screening tag (such as
GFP). In the regular strategy [4], generating and then
cloning an epPCR library into a Gateway
® reporter
expression plasmid requires three steps (Figure 1, stage
1, left flowchart). In the first step, the epPCR product
(dark grey in Figure 1, stage 1) is generated using two
primers hybridizing to the 5’ and 3’ ends of the coding
sequence desired to be subjected to epPCR and flanked
at their respective 5’ end by Gateway
® attB1 and attB2
recombination sites (25-mer), and a PCR template con-
sisting of the wt target sequence (light-grey in Figure 1,
stage 1). In the second step, the epPCR product is
inserted in a shuttle plasmid (pDONR201) by mean of a
BP reaction. After E. coli transformation, an aliquot is
spread on kanamycin plates to assess the library com-
plexity, and the remaining is grown in liquid culture
(100 ml). A plasmid medium preparation is then per-
formed to recover the cloned library (pENTR library)
from the liquid culture. In the third step, an aliquot of
the plasmid medium preparation is used in an LR reac-
tion to transfer the inserts from the entry clones of the
pENTR library to a reporter expression plasmid. The LR
reaction is performed as described above for the BP
reaction except that ampicillin is used instead of kana-
mycin. In this procedure, obtaining a high-complexity
library relies on the efficiency of two critical steps,
namely the BP and LR reactions. In the strategy we
developed, the epPCR library is generated using the
attL1 (25-mer) and attL2 (24-mer) primers and the wt
coding sequence already cloned in the pDONR201 plas-
mid as PCR template. Primers attL1 and attL2 respec-
tively hybridize to the “Forward- and Reverse-priming
sites” located upstream and downstream the attL1 (100
bp) and attL2 (100 bp) Gateway
® recombination sites
(Additional file 1: Figure S1). As a result, the epPCR
product is flanked by full-length attL1 and attL2 recom-
bination sites and hence can be directly used in the LR
reaction. This procedure enables to eliminate three steps
of the regular approach: (i) the BP reaction that trans-
fers the epPCR product to pDONR to create the
pENTR library; (ii) the transformation of E. coli with the
pENTR library; (iii) the purification (plasmid medium
preparation) of the latter. Beyond the advantage related
to the reduction of the number of steps, this procedure
also offers the advantage of preserving the library com-
plexity as shown above.
Standard strategy Strategy described in this study
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Mutant in
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expression
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A
A
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Error-prone PCR + DpnI
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K
Figure 1 Overview of the method. The left flowchart is the
standard strategy and the right flowchart is the strategy described
in this study. Brackets on the left indicate the two stages of the
strategy: the epPCR library construction (stage1) and the sub-
cloning of mutant inserts from reporter to non-reporter expression
plasmid (stage 2). ER1 and ER2 denote restriction sites used to clone
the sequence to evolve and create the PCR template of the
standard strategy. Inner arrows with continuous lines are the core of
the method. Outer arrows with dashed lines indicate the pathways
used to transfer the wt sequence to the non-reporter expression
plasmid, and (in the right flowchart only) to create the internally
deleted wtNTAIL in pDEST17O/I. Mutated and wt sequences are
represented by thick dark and light grey lines, respectively. The
internally deleted wt sequence is denoted by an asterisk. Antibiotic
resistance markers are indicated: A, ampicillin resistance; K,
kanamycin resistance.
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Page 3 of 152) Sub-cloning of selected mutated sequences
After mutants of interest have been selected, their cod-
ing sequence must generally be sub-cloned from the
reporter expression plasmid used to screen the epPCR
library to another non-reporter expression plasmid (Fig-
ure 1, stage 2). In the regular strategy [4], this procedure
essentially follows the same process as that used to cre-
ate the random library (compare stage 1 and stage 2 of
Figure 1, left flowchart). In the first step, the mutated
coding sequence is transferred from the reporter expres-
sion plasmid to pDONR201 by mean of a BP reaction.
E. coli cells are transformed with the BP reaction mix-
ture, and transformed cells are selected on kanamycin
plates. Given the efficiency of Gateway
® transfer [1], few
colonies need to be analyzed. The plasmid of each col-
ony is purified by mini-preparation, and then checked
for the presence of the proper insert generally by PCR
using the attL1 and attL2 primers. The plasmid of one
positive pENTR clone is then used as substrate in an LR
reaction to transfer the coding sequence from pDONR
to the non-reporter expression plasmid. The regular
strategy works well when few mutants have to be pro-
cessed, but we realized that it was impractical in direc-
ted evolution projects where many mutated coding
sequences have to be sub-cloned in parallel from repor-
ter to non-reporter expression plasmid(s). Therefore, we
devised the alternative strategy depicted in the right
flowchart of Figure 1, stage 2 and in more details in Fig-
ure 2. This strategy could be described as a hybrid
method between MEGAWHOP [21] and RF cloning
[22]. MEGAWHOP was devised to clone a random
library of linear DNA. In practice, a library of mutated
linear DNA is used as a complementary pair of megapri-
mers in a PCR experiment. The PCR template is the
non mutated DNA sequence borne by the expression
plasmid to be used for screening the library. Since the
hybridization mismatch between the wt sequence borne
by the expression plasmid and each mutated sequence
to sub-clone (i.e., the mutation rate) is low compared to
the homology, the megaprimers hybridize very efficiently
to the wt sequence. During the PCR elongation steps,
the whole plasmid is copied. After amplification, the
PCR template is degraded by DpnI treatment. The final
product is the random library of DNA borne by the
expression plasmid. RF cloning also aims at inserting a
linear double strand DNA into a plasmid, but uses a dif-
ferent approach. In contrast to MEGAWHOP, not the
whole length of the linear DNA to clone is used for
hybridization, but only 24 base pairs at both ends which
are designed to be complementary to the cloning site of
the plasmid. When this linear DNA is used in a PCR
experiment with the cloning plasmid as template, each
24 base flanking extension hybridizes to its complemen-
tary sequence on the plasmid, resulting in a linear
amplification of the plasmid during the PCR elongation
step. After amplification the PCR template is degraded
by DpnI treatment. The final product is the linear DNA
borne by the plasmid. Our sub-cloning technique relies
on the use of megaprimers, as in MEGAWHOP, and on
the annealing of only the ends of the megaprimers, as in
RF cloning. The method consists of two steps. In the
first step, the mutated coding sequence is PCR amplified
using the attB1 and attB2 primers and the reporter
expression plasmid bearing the mutated coding
sequence as template (PCR1, Figures 1 and 2). After
DpnI treatment to remove methylated (i.e. parental)
DNA, the PCR product flanked by full-length attB1 and
attB2 Gateway
® recombination sites is used as a pair of
complementary megaprimers in a second PCR step that
uses an internally deleted form of the wt coding
sequence borne by the non-reporter expression plasmid
as template (PCR2, Figures 1 and 2). The reason for
using an internally deleted sequence as PCR2 template
is explained in the last paragraph of the results section.
The result of this second PCR is the full-length mutated
coding sequence in the non-reporter expression plasmid.
3) Application of the method to the NTAIL-XD
interaction project
We have applied the above-described strategy to few
directed evolution projects (B. Coutard, F. Vincent,
unpublished data), including the one reported herein. In
view of gaining insights into the NTAIL-XD interaction,
we generated a mutant library of NTAIL and used a split
Table 2 Plasmid constructs used in this study
Name Insert Source Purpose
pET11a-link-
NGFP
None [7] pNGG backbone
pNGG Gateway cassette This
study
Library screening
pNGG-NTAIL NTAIL This
study
Positive control
pNGG-Stop-NTAIL Stop-NTAIL This
study
Negative control
pDONR-Stop-
NTAIL
Stop-NTAIL This
study
LR substrate
pDONR-NTAIL NTAIL This
study
epPCR substrate
pET11a-Z-NGFP Leucine zipper [7] Positive control
pMRBAD-Z-CGFP Leucine zipper [7] Positive control
pMRBAD-link-
CGFP
None [7] CGFP cloning
backbone
pMRBAD-XD-
CGFP
XD This
study
NTAIL interacting
partner
pDEST17O/I-
NTAIL
NTAIL This
study
idNTAIL PCR template
pDEST17O/I-
idNTAIL
Internally deleted
NTAIL
This
study
PCR2 template
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SalI digestion followed   by self-ligation 
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Figure 2 Schematic of the sub-cloning of a mutated sequence from reporter to non-reporter expression plasmid. From top to bottom,
the DNA fragments amplified by PCR between the T7prom and attB2 primers are 1,046 bp, 333 bp, and 560 bp in length, respectively. On the
right is illustrated how inverse PCR was used to internally delete 227 bp from the wtNTAIL sequence in pDEST17O/I. Plasmids are not at scale.
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Page 5 of 15GFP re-assembly assay to screen variants with altered
interaction abilities [18-20]. In this method, the
sequence coding for one of the two interacting partners
under study is inserted in the prokaryotic expression
vector pET11a-link-NGFP so as to lead to its expression
as a fusion protein with the N-terminal half of GFP
(NGFP). The coding sequence of the second interacting
partner is inserted in another prokaryotic expression
vector (pMRBAD-link-CGFP) thus leading to its expres-
sion as a fusion protein with the C-terminal half of GFP
(CGFP). Both fusion proteins are then co-expressed in
E. coli. If the two proteins of interest interact with each
other in the bacterium, their interaction allows the two
GFP halves to re-associate and reconstitute the func-
tional (i.e., fluorescent) GFP. Thus, fluorescent bacteria
denote an interaction between the two partners, with
the fluorescence intensity being proportional to the affi-
nity of this interaction. In practice, a library of NTAIL
random mutants was inserted in a modified pET11a-
link-NGFP vector (see below), and mutants were
screened for altered interacting abilities with wtXD
expressed from pMRBAD-XD-CGFP.
Since neither pET11a-link-NGFP nor pMRBAD-link-
CGFP are Gateway
® plasmids, as a first step in this pro-
ject we modified pET11a-link-NGFP to make it a Gate-
way
® reporter expression plasmid. This conversion is
generally performed by inserting a blunt-end synthetic
cassette that is flanked by attR1 and attR2 recombina-
tion sites, and bears two constitutive genes: a chloram-
phenicol resistance (Cm
r) gene, and a counter-selectable
(ccdB) gene. The cassette can be purchased from Invi-
trogen in three reading frames, and is intended to be
inserted in a blunt (or blunted) restriction site of the
plasmid to modify. However, such a restriction site may
not exist at the desired position, and blunt end cloning
requires screening not only for cassette-containing plas-
mids but also for the correct orientation of the cassette
with regard to the promoter. Since pET11a-link-NGFP
cloning site contains two restriction sites (XhoI and
BamHI), an alternative to the classical approach was to
PCR amplify the cassette using whatever Gateway
® des-
tination plasmid as template and primers hybridizing to
the 5’ and 3’ e n d so ft h ec a s s e t t ea n df l a n k e db yX h o I
and BamHI restriction sites, respectively. Unfortunately,
because of the high homology between the 5’ and 3’
ends of the Gateway
® cassette (Figure 3A), each primer
was found to be able to hybridize to both ends of the
cassette (Figure 3B). To circumvent this problem, we
devised the strategy depicted in Figure 3C. To prevent
hybridization of the 5’ primer with the 3’primer site and
vice versa,t h e5 ’ and 3’ h a l v e so ft h ec a s s e t t ew e r eP C R
amplified separately (PCR tube 1 and PCR tube 2, Fig-
ure 3C) using the Gateway
® destination plasmid pTH31
[4] as template. This template contained a single BamHI
restriction site in the middle of the cassette which had
to be mutated before cloning. We took advantage of its
central location to develop a pair of internal overlapping
primers (primers 2 and 3) encoding a mutated BamHI
site to mutate the internal BamHI restriction site during
the amplification of the two cassette halves. Internal
PCR primers 2 and 3 were 100% complementary to
each other, so that the PCR products from tube 1 and
tube 2 overlapped. After DpnI treatment to remove the
template, and purification of the PCR products to
remove PCR primers, a third PCR was run that only
used an equimolar amount of the two PCR products, i.
e., without adding external primers nor template (PCR
tube 3, Figure 3C). This “elongation PCR” reconstituted
the full-length cassette which was then ligated into
pET11a-link-NGFP after BamHI and XhoI digestion.
This Gateway
® reporter expression plasmid was called
pNGG (plasmid N-GFP Gateway
®) and is available upon
request. Incidentally, this “two halves” strategy is gener-
ally applicable whenever direct directional cloning is
hampered by a high homology of the two PCR primers.
In a first step, the efficiency of LR reactions using dif-
ferent donors and acceptors was evaluated under differ-
ent experimental conditions. We first assessed the
efficiency of an LR reaction that made use of a non-
mutated linear molecular species bearing attL recombi-
nation sites at the extremities (wtNTAIL-PCR, which
could be described as a “ghost pENTR clone” since it is
devoid of most of the pENTR backbone) and a circular
Gateway
® reporter expression plasmid (non-linearized
pNGG), and compared it to that of LR reactions that
were carried out with different combinations of linear
and non-linear substrates. The results are reported in
Table 4. The combination used in the strategy we
devised, i.e. wtNTAIL-PCR and non-linearized pNGG
(Table 4, line 3), provided at least as good results as the
other combinations, in particular when compared to the
reference wtNTAIL-pDONR/non-linearized pNGG com-
bination (Table 4, line 1). Thus, a linear DNA flanked
by full-length attL recombination sites proved to be an
efficient substrate for the LR reaction. We also checked
whether the use of non-equimolar ratios of either LR
reaction substrates, as suggested by Invitrogen, was opti-
mal. The results, reported in Table 3, indicated that 100
fmoles of the donor construct and 25 fmoles of the
acceptor construct provided at least as good results as
an equimolar amount (100 fmoles of each), suggesting
that 25 fmoles of non-linearized pNGG did not limit the
LR reaction efficiency under these experimental condi-
tions. The strategy we devised relies on the use of a pair
of generic attL primers to generate an epPCR product
flanked by the full-length attL1 and attL2 recombina-
tion sites (Stage 1 in the right flowchart of Figure 1).
Since each attL recombination site is 100 bp long
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attR1 attR2 
(1)
(2) 
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XhoI attR1
Mutated 
BamHI 
PCR using only purified PCR1 and PCR2 products 
pTH31  
attR1 attR2 
(4)
(3) 
attR2
PCR2 followed  by DpnI digestion 
PCR tube 2
PCR tube 3
XhoI attR1
Mutated 
BamHI  BamHI attR2
pNGG  
attR1 attR2 
Gateway cassette
T7P
His-NGFP
XhoI BamHI 
Ligation after 
XhoI and 
BamHI 
digestion pET11a-link-NGFP  
T7P
His-NGFP
XhoI
BamHI 
AB
C
M                    1                    2                 3
2000 
1500 
1000 
      5'end -----------ACAAGTTTGTACAAAAAAGCTGAA
      3'end ------------CCACTTTGTACAAGAAAGCTGAA
XhoI-attR1  GGGGCTCGAGTACAAGTTTGTACAAAAAAGCTGAA
BamHI-attR2 -GGGGGGATCCACCACTTTGTACAAGAAAGCT---
Identity                * * ********* ******   
BamHI BamHI PCR tube 1
Mutated 
BamHI  BamHI
Figure 3 Construction of pNGG.( A) Alignment of (from top to bottom): the 5’ and 3’ ends of pTH31 Gateway
® cassette; XhoI-attR1 PCR primer;
BamHI-attR2 PCR primer. Sequence identity is denoted by asterisks below the alignment. (B) The Gateway
® cassette was PCR amplified using
pTH31 as template, and either primer XhoI-attR1 alone (lane 1), primer BamHI-attR2 alone (lane 2), or primers XhoI-attR1 and BamHI-attR2 (lane 3).
Markers size is indicated on the left in base pairs. (C) “Two-halves” making of pNGG. The plasmids are not at scale. Light grey, Gateway cassette.
Black, attR recombination sites. Primer (1), XhoI-attR1. Primer (2), BamHI-mut-R. Primer (3), BamHI-mut-F. Primer (4), BamHI-attR2 (Table 3).
Gruet et al. Microbial Cell Factories 2012, 11:14
http://www.microbialcellfactories.com/content/11/1/14
Page 7 of 15(Additional file 1: Figure S1), a risk potentially existed
that mutations had been introduced by Mutazyme II in
these sites during epPCR elongation steps. This would
lead to an epPCR product partly unsuitable for the LR
reaction, thereby ultimately resulting in a library com-
plexity drop. As one can see in the first two lines of
T a b l e5 ,1 0 0a n de v e n1 0f m o l e so fN TAIL-epPCR pro-
duct provided at least as many clones as did 100 fmoles
of NTAIL-PCR product generated by a proof-reading Taq
polymerase (Table 4 third line, and Table 3 first line).
This suggests that if mutations occurred in the attL
recombination sites during the epPCR, they did not
interfere with the downstream LR reaction. This result
is not completely surprising since it has been shown
that deleting as much as 50% of attL recombinant site
did not significantly reduce the percentage of recombi-
nant clones [23]. Finally, we investigated the reproduci-
bility of our approach. As shown in Table 5 (last three
lines), the results obtained with NTAIL/pNGG were not
unique to this system, as comparable results were
obtained when coding sequences with a composition
and length (LadS, PA3059) different from that of NTAIL
were used in LR reactions with another reporter expres-
sion plasmid (pTH31). This suggested that using a linear
DNA generated by epPCR flanked by attLs i t e s ,a n da
non-linearized plasmid in the LR reaction was a gener-
ally applicable method.
In the next step, we evaluated the ability of our
method for generating epPCR libraries (Stage 1 in the
right flowchart of Figure 1) to provide mutants of inter-
est. To that end, an epPCR library of NTAIL in pNGG
(Table 5, second line) was screened for clones displaying
higher or lower fluorescence with respect to that of
wtNTAIL when co-expressed with XD as described in
Methods. More than 300 clones complying with these
criteria were manually selected and characterized in
terms of their fluorescence and of their sequence (Gruet
et al., unpublished results). The latter revealed an aver-
age mutation rate of 1% base pairs. Attempts to increase
this rate by performing additional epPCRs failed for the
reasons explained in Additional file 2: Figure S2. Figure
4A shows the fluorescence of a representative sample of
the selected clones. Antiparallel leucine zippers (Z)
(pET11a-Z-NGFP and pMRBAD-Z-CGFP) were used as
positive control of interaction [18] because of their high
affinity, expression, and solubility. An NTAIL coding
sequence with an in-frame stop codon located just
downstream attB1 was used as negative control (Stop-
NTAIL, S). This construct expresses only the NGFP moi-
ety which is unable to interact with XD-CGFP. The
reference fluorescence value was provided by wtNTAIL
(N). A representative set of 4 mutants (1-4) with a fluor-
escence similar to or lower than that of wtNTAIL is
reported. The relationship between the mutations borne
by these mutants (Additional file 3: Text S1) and their
specific fluorescence is beyond the scope of this study
and will be discussed elsewhere (Gruet et al., unpub-
lished results). Notably, clone 4 featured a stop codon
(R489 (CGA) > (TGA) Stop) that resulted in a truncated
form of NTAIL. Interestingly, this deletion perfectly
mimics an already published variant (NTAILΔ2,3) that had
been shown to display a considerably lower (two orders
of magnitude) affinity towards XD [10]. Since we could
not rule out a priori that a decreased fluorescence could
be due to decreased protein expression and not to
decreased NTAIL-NGFP/XD-CGFP interaction, we
Table 4 Comparison of expression library complexities
provided by different combinations of linear and non-
linear LR substrates using wtNTAIL sequence.
Donor Acceptor construct Number of clones
wtNTAIL-pDONR
1 Non-linearized pNGG 0.3 × 10
7
wtNTAIL-pDONR
1 SalI-linearized pNGG 0.4 × 10
7
wtNTAIL-PCR
2 Non-linearized pNGG 1.6 × 10
7
wtNTAIL-PCR
2 SalI-linearized pNGG 0.25 × 10
7
The number of E. coli colonies provided by various combinations of 100
fmoles of donor and of 25 fmoles of acceptor construct in a 5 μl LR reaction
is reported. T7pRos E. coli cells were electroporated and spread on ACplates
1wtNTAIL coding sequence borne by pDONR.
2wtNTAIL coding sequence
amplified using attL1 and attL2 primers
Table 5 Comparison of expression library complexities
provided by different combinations of epPCR products
and of non-linearized acceptor constructs
epPCR product Non-linearized acceptor
construct
Number of
clones
NTAIL
1 10 fmoles pNGG
4 2.8 × 10
7
NTAIL
1 100 fmoles pNGG
4 3.25 × 10
7
LadS
2 10 fmoles pTH31
5 6.65 × 10
7
LadS
2 100 fmoles pTH31
5 3.85 × 10
7
PA3059
3 42
fmoles
pTH31
5 1×1 0
7
The number of E. coli colonies provided by various combinations of epPCR
product and of 25 fmoles of acceptor constructs in 5 μl of LR reaction is
reported. T7pRos E. coli cells were electroporated and spread on ACplates
1NTAIL PCR product is 661 bp.
2LadS PCR product is 696 bp.
3PA3059 PCR
product is 1,780 bp. These three PCR product lengths include the attL1 and
attL2 recombination sites.
4pNGG is 8,012 bp before LR recombination.
5pTH31 is 8,306 bp before LR recombination.
Table 3 Effect of the molar ratios of wtNTAIL-PCR (donor)
and non-linearized pNGG (acceptor construct).
Donor Acceptor construct Number of clones
Electroporation 100 fmoles 25 fmoles 0.95 × 10
7
100 fmoles 100 fmoles 0.4 × 10
7
Heat shock 100 fmoles 25 fmoles 0.47 × 10
5
100 fmoles 100 fmoles 0.16 × 10
5
The number of E. coli colonies provided by using two molar ratios of donor
and acceptor construct in a 5 μl LR reaction is reported. T7pRos E. coli cells
were treated as described in Table 1
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NTAIL-NGFP clones (S, N, 1-4). Taking advantage of the
presence of a 6His tag appended at the N-terminus of
NGFP [18], the His-tagged proteins expressed by clones
Z, S, N, and 1-4 were purified by immobilized metal
(Ni
2+) affinity chromatography (IMAC) from the total E
coli lysate under denaturing conditions, or from the
soluble fraction of this latter under non denaturing con-
ditions. The eluants from IMAC were analyzed by SDS-
PAGE (Figure 4B). Notably, Stop-NTAIL, wtNTAIL,a n d
all four mutants exhibited comparable levels of total
expression of the NGFP-NTAIL fusion protein (arrows 1
a n d2i nF i g u r e4 B )s u g g e s t i n g that fluorescence differ-
ences were due to different interaction abilities and not
to different protein expression levels. Moreover, the
expression level of the NGFP-NTAIL protein by the non-
fluorescent mutant 4 was even slightly higher than that
of the other mutants (arrow 2 in Figure 4B). Under non
denaturing conditions, the interacting partner fused to
CGFP and devoid of His-tag (arrows 5 and 6 in Figure
4B) was co-purified with the His-tagged protein. As
expected, its amount paralleled the fluorescence intensi-
ties reported in Figure 4A. By contrast, when proteins
were purified by IMAC under denaturing conditions,
only the His-tagged moiety was recovered from total E
coli lysate. Altogether, these results indicate that differ-
ent NTAIL-XD interaction capabilities due to specific
mutations in the NTAIL sequence and not different
NTAIL expression levels accounted for the different
fluorescence intensities reported in Figure 4A. Thus, our
one step method for generating epPCR libraries (Stage 1
in the right flowchart of Figure 1) proves to be an effec-
tive mean to yield mutants of interest.
In view of investigating interaction capabilities in the
absence of the GFP moiety (to be published elsewhere),
the mutated NTAIL coding sequences were sub-cloned
from pNGG (reporter expression plasmid) to
pDEST17O/I (non-reporter expression plasmid), a
frame-compatible plasmid allowing proteins to be
expressed with a simple N-terminal His-tag [24]. Sub-
cloning was performed as described above (Figure 1,
stage 2, right panel and Figure 2). The efficiency of this
approach is highly dependent on the efficiency of DpnI
treatment performed after each PCR. An inefficient
DpnI treatment after PCR1 would generate a back-
ground made of the donor construct (mutant sequence
in pNGG). An inefficient DpnI treatment after PCR2
would generate a background made of the acceptor con-
struct (wt sequence in pDEST17O/I). Unfortunately, this
signal-to-noise ratio could be appraised only by sequen-
cing plasmids borne by several randomly chosen clones.
To avoid sequencing PCR1 or PCR2 background, we
introduced a screening step so as to be able to distin-
guish background plasmids from the desired construct.
The easiest way to do that was to use a pair of screening
primers that amplify fragments of different lengths from
the three possible constructs (i.e., the correct construct,
and PCR1 and PCR2 backgrounds). Although a primer
pair made of T7prom and attB2 primers could distin-
guish pNGG from pDEST17O/I, it failed to differentiate
am u t a t e dN TAIL from the wtNTAIL sequence in
pDEST17O/I, as both have the same length. A solution
to this issue was to use as template in PCR2 an intern-
ally deleted wtNTAIL sequence (Figure 2) instead of the
full-length sequence as envisaged by MEGAWHOP [21].
The internally deleted (227 bp deletion) NTAIL borne by
pDEST17O/I (pDEST17O/I-idNTAIL,T a b l e2 )w a sc o n -
structed by inverse PCR using the pDEST17O/I-NTAIL
plasmid (Table 2) as template and primers p17O/ISal1F
and p17O/ISal1R (Table 6). Following DpnI digestion,
the PCR product was purified and then digested with
SalI and self-ligated (Figure 2). Under these conditions,
PCR screening E. coli colonies after transformation with
DpnI-treated PCR2 product using T7prom and attB2
primers was expected to lead to amplification of either a
1,046 bp band (PCR1 background), or a 560 bp band
(correct construct), or a 333 bp band (PCR2 back-
ground). Typical PCR screening results are reported in
Figure 4C. First experiments (experiment I in Figure 4C)
revealed a low signal (i.e., correct construct) to back-
ground ratio. In gel I, clone 1 was PCR2 background,
while clones 2, 3, 6 and 7 were PCR1 background and
only clones 4 and 5 contained the correct construct.
The high background (5 clones out of 7) denoted ineffi-
cient DpnI treatments, particularly after PCR1 (4 clones
out of 7). This issue was addressed in two different
ways. Firstly, we reduced the background by improving
DpnI treatment and by reducing the amount of the tem-
plate used in PCR1 as the PCR template is responsible
for the background. Secondly, as the signal is propor-
tional to (and limited by) the amount of megaprimers
used in PCR2 we increased the signal by increasing the
amount of megaprimers produced by PCR1. In practice,
to both increase the signal and decrease the background
we combined several modifications of the reaction: more
DpnI was used for longer incubation times, more of
each primer, more PCR cycles, larger PCR volumes and
less PCR template were used in experiments II and III
(Additional file 4: Table S1) to generate the megapri-
mers (PCR1). In experiment II, the template used for
PCR2 was full-length NTAIL in pDEST17O/I. The new
experimental conditions (Additional file 4: Table S1)
completely abolished PCR1 background (no band
detectable at 1,046 bp in Figure 4C, experiment II).
However, the use of full-length NTAIL in pDEST17O/I
as template in PCR2 did not allow detecting PCR2 back-
g r o u n d .T h e r e f o r e ,a ne x p e r i m e n tw a sp e r f o r m e da si n
experiment II except that internally deleted NTAIL in
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Figure 4 Representative results of library screening and sub-cloning experiments.( A) The fluorescence to OD600 ratio (mean value and
standard deviation of a triplicate experiment) of the clones indicated on the × axis were determined as described in Methods. Z, Leucine
zippers; S, Stop-NTAIL;N ,wtNTAIL; 1-3, full length mutated NTAIL; 4, truncated NTAIL mutant. (B) His-tagged proteins expressed by clones Z, S, N, 1-4
(Figure 4A) were purified by affinity chromatography on IMAC as described in Methods, and were analyzed by SDS-PAGE using 15%
polyacrylamide gels and Coomassie blue staining. Soluble, His-tagged proteins were purified under non denaturing conditions from the soluble
fraction of the E. coli lysate. Total, His-tagged proteins were purified under denaturing conditions from total E. coli lysate. Soluble and total
fractions were obtained from a duplicate culture. M, molecular size markers (from top to bottom: 170, 130, 100, 70, 55, 40, 35, 25, 15, 10 kDa).
Arrows indicate the different purified proteins: 1, NGFP- wtNTAIL and NGFP-full-length NTAIL variants (34 kDa); 2, NGFP-truncated NTAIL variant 4
(29.4 kDa); 3, NGP-Z (22.8 kDa); 4, NGFP (i.e., Stop-NTAIL) (20.4 kDa); 5, XD-CGFP (15.5 kDa); 6, Z-CGFP (13.3 kDa). (C) PCR screening of mutated
NTAIL sub-cloning experiment from pNGG to pDEST17O/I. PCR control a, 1,046 bp; b, 560 bp; c, 333 bp. PCR screening II and III were run in the
same gel along with controls a, b, and c. M, molecular size markers (from top to bottom: 2000, 1500, 1000, 750, 500, 250 bp).
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(experiment III in Figure 4C) confirmed the absence of
PCR1 background and pointed out a low level (similar
to that of experiment I although PCR2 template had
been increased, see Additional file 4: Table S1) of PCR2
background. PCR-positive clones 1, 2, 3 and 5 from
experiment III were sequenced, and proved to bear the
correct insert in the correct plasmid. In addition,
sequencing ruled out the presence of any unwanted
mutations that could have been introduced because of
the increase (from 10 to 30) in the number of cycles in
PCR1.
Discussion
In this study, we described a new method for creating
high complexity epPCR libraries based on a modified
use of the Gateway
® recombination cloning technology.
Compared to the conventional Gateway
® protocol ([4]
and stage 1 in the left flowchart of Figure 1), our
method is faster as it skips some steps such as the BP
reaction and the associated E. coli transformation and
plasmid purification. Note that although we only used
epPCR for generating random mutant libraries, we
believe that our strategy could be easily applied to the
generation of libraries based on DNA shuffling [2].
Since the conventional sub-cloning of selected mutated
sequences requires the same steps as those typically
used to create the library ([4] and stage 2 in the left
flowchart of Figure 1), we also devised a sub-cloning
strategy that allows several mutant sequences to be sub-
cloned in parallel from the reporter expression plasmid
used to screen the library to another expression plasmid
devoid of the screening tag (GFP in this case). We have
applied and validated the method in three directed evo-
lution projects, and provided here the first results
obtained in the case of the NTAIL-XD system. In the
other two projects, we constructed other epPCR libraries
that made use of other target sequences to evolve, as
well as of another reporter expression plasmid. In all
cases, comparable library complexities were obtained
(Table 5 and unpublished data).
As shown in Table 1, skipping the BP reaction used in
the standard protocol to clone the epPCR product in
pDONR (stage 1 in Figure 1) appears to preserve the
library complexity. However, one may argue that the
price paid for this preservation is that the wt sequence
must first be cloned into pDONR, and so the benefit of
our strategy (i.e. the reduction in the number of steps)
would be abrogated by this first mandatory “pre-clon-
ing” BP reaction. We would like to point out that this is
not the case. This starting construct is instrumental not
only in the epPCR step but also, directly or indirectly, in
three other steps of our procedure (see dashed line in
the right flowchart of Figure 1). Firstly, this pDONR
construct bearing the wt sequence is required to gener-
ate by LR reaction the pDEST17O/I-wtNTAIL construct
(i.e. the non-reporter expression plasmid bearing the wt
sequence) that will be used as a control in comparative
Table 6 Primers used in this study
Name Sequence Purpose
Nco1-MeV.
XD
GGGGCCATGGGCGCATCACGCAGTGTAATCCGCTCC XD PCR amplification
MeV.XD-AatII GGGGGACGTCGACTTCATTATTATCTTCACCAGCAT
NTAILF GGGGACAAGTTTGTACAAAAAAGCAGGCTCTACTACTGAGGACAAGATCAGTAGA NTAIL PCR amplification
NTAILR AGCTTTCTTGTACAAAGTGGTGGATCCCCCC
StopNtail GGGGACAAGTTTGTACAAAAAAGCAGGCTCTTAATAAACTACTGAGGACAAGATCAGTAGA StopNtail PCR amplification
XhoI-attR1
(primer 1)
GGGGCTCGAGTACAAGTTTGTACAAAAAAGCTGAA pNGG construction (Gateway
® cassette 5’
halve)
BamHI-mut-R
(primer 2)
TCTGGCTTTTAGTAAGCCGGAACCTCTAGATTACGCCCCGCCCTG
BamHI-mut-F
(primer 3)
CAGGGCGGGGCGTAATCTAGAGGTTCCGGCTTACTAAAAGCCAGA pNGG construction (Gateway
® cassette 3’
halve)
BamHI-attR2
(primer 4)
GGGGGGATCCACCACTTTGTACAAGAAAGCT
p17O/ISal1F GGGGGTCGACGCAGGAATCTCGGAAGAACAAGGC PCR construction of pDEST17O/I-idNTAIL
p17O/ISal1R GGGGGTCGACCGTGTAGAAATGATACTTGGGC
T7prom TAATACGACTCACTATAGG Sub-cloning screening
attB2 CCACTTTGTACAAGAAAGCTGGGT
attL1 TCGCGTTAACGCTAGCATGGATCTC epPCR
attL2 GTAACATCAGAGATTTTGAGACAC
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sequences (Figure 1). Secondly, pDEST17O/I-wtNTAIL
allows the construction of the internally deleted tem-
plate used in the sub-cloning (Figure 2). Thirdly,
pDEST17O/I-wtNTAIL also provides a positive control in
PCR screenings aimed at avoiding the sequencing of
background clones (Figure 4C). By contrast, since the
standard strategy (stage 1 in the left flowchart of Figure
1) used a non Gateway
® plasmid as template for the
epPCR, the same result will require much more work
and steps (compare dashed lines in the left and right
flowcharts of Figure 1). Thus, what could first appear as
a constraint finally proves to be a saving of time when
compared to the standard protocol.
RF cloning and MEGAWHOP could not be used in
our sub-cloning protocol exactly as they were published,
and needed to be adapted for the following reasons. In
the published RF cloning technique [22], PCR1 was per-
formed using genomic DNA as template, and so ineffi-
cient DpnI digestion would simply result in bacteria
being transformed with genomic DNA. Since the latter
did not provide any antibiotic resistance it could not
generate any background, whereas the template was
responsible for PCR1 background in our case (Figure
4C). In the case of MEGAWHOP [21], donor and
acceptor plasmids were the same. Here again, inefficient
DpnI digestion of PCR2 product would only increase
the amount of non mutated sequences in the final
epPCR library, a situation frequently encountered even
at high mutagenesis rates (A. Gruet, unpublished obser-
vations), whereas it was responsible for PCR2 back-
ground in our case (Figure 4C).
It is noteworthy that the sub-cloning method that we
developed was made possible because of the following
two features. Firstly, donor (pNGG) and acceptor
(pDEST17O/I) plasmids were both Gateway
® plasmids
and hence shared common 5’ and 3’ PCR priming sites.
Moreover, these PCR priming sites did not require spe-
cific but generic attB1 and attB2 primers. Secondly,
thanks to the specific founding features of Gateway
®,
pNGG and pDEST17O/I were 5’ and 3’ reading frame
compatible, a feature that can be easily obtained for any
expression plasmid suitably modified to bear the Gate-
way
® cassette. For example, we have taken advantage of
this feature to sub-clone mutated coding sequences
from pTH31 to pTH24 [4] in another directed evolution
project (B. Coutard, unpublished results).
Although it does simplify sub-cloning when more than
five mutant coding sequences have to be processed in
parallel, the sub-cloning strategy that we devised could
be further optimized by using a PCR2 template that
could be detected directly on plates. This would save
the time devoted to pick up and grow randomly chosen
clones and to purify and screen their plasmids so as to
distinguish them from those from background colonies.
Actually, we sought at using Rubredoxin [25] as such a
possible phenotypic marker of PCR2 background.
Unfortunately however, following transformation of E.
coli with a pDEST17O/I plasmid bearing the sequence
of a synthetic Thermotoga maritima Rubredoxin gene
(NCBI reference sequence: NP_228468.1) that had been
optimized for translation in E. coli, no red colonies were
obtained (data not shown). Another even more stringent
mean would be to use a ccdB constitutive gene in
pDEST17O/I instead of an internally deleted NTAIL [26].
In that case, there would be no PCR2 background as
clones bearing the ccdB gene are not viable.
Before concluding, we would like to point out that the
method described here is proposed as a toolbox made
of three independent parts: (i) the production of epPCR
libraries, (ii) the “two halves” construction of a Gate-
way
® plasmid, (iii) a sub-cloning strategy. The NTAIL-
XD project provided an opportunity to describe a com-
bined usage of the three parts, but these can be used
separately (B. Coutard, unpublished results).
The Gateway
® cloning technology has been a tremen-
dous breakthrough since it was implemented in the
early 2000s. Perhaps not by chance, its commercial
availability happened to coincide with the beginning of
the Structural Genomics era. This coincidence undoubt-
edly helped Structural Genomics programs to comply
with their time schedule [1]. To our surprise, we have
been unable to find numerous directed evolution pro-
jects that made use of the Gateway
® technology. We
hope that the modified protocol described in this study
will contribute to a broader usage of this powerful tech-
nology in studies aimed at evolving proteins.
Conclusions
We have described a method to create high complexity
epPRC libraries using only the LR reaction of the Gate-
way
® cloning technology. Directly cloning an epPCR
product in the plasmid used for screening the library
allows eliminating not only the BP reaction but also the
associated E. coli cell transformation and plasmid purifi-
cation required by the usual Gateway
® procedure. Thus,
the same result can be obtained with half the amount of
work.
Methods
Materials
Turbo broth (TB) was from AthenaES™.N u c l e o S p i n
®
Extract II and NucleoSpin
® Plasmid kit (Macherey-
Nagel) were used for purifying PCR products and for
plasmid mini-preparations, respectively. DNA ligations
were performed using Quick Ligation Kit (Roche). Gen-
eMorph
® II Random Mutagenesis Kit (Stratagene) was
used for epPCR experiments. Preparative and analytical
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(Invitrogen), respectively. All primers were purchased
from Operon. DNA sequencing was performed by
GATC Biotech.
DNA constructs
pMRBAD-link-CGFP [19], encoding the C-terminal half
(aa 158-238) of eGFP under the control of the PBAD
promoter (inducible by L-arabinose) and allowing
upstream in frame cloning of DNA fragments, was a
kind gift of Lynne Regan, as were pET11a-link-NGFP,
pET11a-Z-NGFP and pMRBAD-Z-CGFP. These latter
two encode fusion proteins between leucine zippers and
t h et w oh a l v e so ft h ee G F P ,w h i l ep E T 1 1 a - l i n k - N G F P
encodes the N-terminal half (aa 1-157) of eGFP under
the control of the T7 promoter (inducible by IPTG) and
allows downstream in-frame cloning of DNA fragments
[19]. pMRBAD-XD-CGFP was constructed as follows.
The coding sequence of XD was PCR amplified using
primers Nco1-MeV.XD and MeV.XD-AatII (Table 6)
and a plasmid encoding the X domain (aa 459-507) of
the measles virus phosphoprotein (strain Edmonston B)
(pDEST14/XDHC) as template [9]. DpnI-treated purified
PCR product and pMRBAD-link-CGFP were ligated
after NcoI and AatII digestion. pDONR-NTAIL was
obtained by BP reaction with a PCR NTAIL fragment
amplified using primers NTAILFa n dN TAILR( T a b l e6 ) ,
and a plasmid encoding the measles virus nucleoprotein
(strain Edmonston B) (pET-21a/N) as template [27].
pDONR-Stop-NTAIL was obtained by BP reaction with a
PCR NTAIL fragment amplified using primers StopNtail
and NTAILR( T a b l e6 )a n dp D O N R - N TAIL as template.
StopNtail has two Stop codons before the first NTAIL
codon. pNGG-NTAIL and pNGG-Stop-NTAIL were
obtained by LR reaction using pNGG as destination vec-
tor and pDONR-NTAIL or pDONR-Stop-NTAIL as donor
constructs, respectively. pDEST17O/I-NTAIL was
obtained by LR reaction using pDONR-NTAIL and
pDEST17O/I [24]. The constructs were verified by
sequencing and found to conform to expectations. The
plasmids used in this study are summarized in Table 2.
Strains and electroporation
DB3.1 cells (Invitrogen) were used to propagate non
recombined Gateway
® plasmids, and TAM1 cells (Active
Motif) to propagate non-Gateway
® and recombined
Gateway
® plasmids. T7 cells (New England Biolabs)
bearing the pLysS plasmid from Rosetta(DE3)pLysS cell
(Novagen) (referred to as T7pRos) were used for protein
expression and for epPCR library screening.
Electrocompetent T7pRos cells were prepared as fol-
lows. Frozen cells that had been previously transformed
with pMRBAD-XD-CGFP were used to seed 1 L of LB
containing 50 μg/ml kanamycin and 34 μg/ml
chloramphenicol, and allowed to grow until OD600 =
0.5. The cells were recovered by centrifugation for 10
min at 5000 g, and resuspended in 400 ml of ice-cold
water. Three additional washings were performed using
300 and then 200 ml of ice-cold water. The cells were
then washed with 80 ml of ice-cold 10% glycerol, and
finally re-suspended in 4 ml of the same buffer. Aliquots
of 1 ml were stored frozen at -80°C until use. For elec-
troporation, 50 μl of cells were mixed with 1 μlo fD N A
and electroporated in 1 mm wide cuvettes (Eurogentec
CE-0001-50) at 1660 V using an Eppendorf electropora-
tor 2510. Under these conditions, an average time con-
stant of ~5.4 milliseconds was observed.
Error-prone PCR and Gateway
® cloning
Error-prone PCR experiments were performed following
the indications provided by the GeneMorph
® II Random
Mutagenesis Kit instruction manual (Stratagene) using
10 ng of template in 50 μl of PCR mix. At the end of
the PCR, 1 μl (20 U) of DpnI (New-England Biolabs)
was added to the PCR mix which was then incubated
for 1 h at 37°C. After purification, the quality and quan-
tity of the PCR product were estimated as described in
the kit manual and by spectrophotometry.
LR reactions were performed overnight at 26°C in a
dry incubator in a final volume of 5 μlc o n t a i n i n g1 . 5μl
of each of the donor and acceptor construct, 1 μlo f5 ×
LR buffer, and 1 μl of LR clonase enzyme mix (Invitro-
gen). The next day, 1 μlo fa2μg/μl proteinase K solu-
tion (Euromedex, EU0090) was added and the reaction
mix was incubated for 15 min at 37°C. LR reactions
were diluted to 50 μl with water, and 1 μl of this dilu-
tion was used to electroporate T7pRos cells as described
above. Immediately after electroporation, the cells were
resuspended in 15 ml of SOC medium, and then incu-
bated for 1 hour at 37°C under 200 rpm shaking. Serial
dilutions of an aliquot were plated on AKCplate to
assess the complexity of the library. The remaining bac-
terial suspension was supplemented with ampicillin,
kanamycin and chloramphenicol at a final concentration
of 100, 50 and 34 μg/ml, respectively, and grown at 37°
C under 200 rpm shaking. When the culture medium
became turbid (~5 h), it was supplemented with glycerol
at a final concentration of 20% (volume/volume), and
300 μl aliquots were frozen at -80°C.
Library screening
An aliquot of the library was thawed and serial dilu-
tions were spread on AKCplates to assess the number
of clones. An aliquot from the same tube was then
spread on AKCplates at a cell density allowing isolated
colonies to be obtained after overnight growth at 37°C.
Colonies were randomly picked up and individually
grown at 37°C overnight under 700 rpm shaking in 500
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Page 13 of 15μlo fT Bc o n t a i n i n g1 0 0μg/ml ampicillin, 50 μg/ml
kanamycin and 34 μg/ml chloramphenicol (TBAKC) in
a 96-well deep-well plate. The next day, another 96-
well deep-well plate containing the same volume of the
same culture medium was seeded with 50 μlo ft h e
overnight culture, and the remaining pre-culture was
used to individually seed 96-well ampicillin agar plates
provided by GATC Biotech and sent to the same com-
pany for plasmid purification and sequencing. The
freshly seeded deep-well plate was grown for 1 h at 37°
C under 700 rpm shaking. IPTG and arabinose were
then added at final concentrations of 0.5 mM and 2%,
respectively, and protein expression was allowed to
proceed at 17°C for at least 20 h. Culture medium, cul-
ture temperature during protein expression, and IPTG
and arabinose concentrations leading to the best sig-
nal-to-noise ratio were determined by using a frac-
tional factorial approach modified from [28], the detail
of which are provided in Additional file 5: Figure S3.
At the end of the culture, the deep-well plate was spun
for 3 min at 1,500 g and the culture medium discarded.
The cell pellets were re-suspended in 500 μlo fP B Sb y
s h a k i n ga t7 0 0r p mf o r2 0m i na t1 7 ° C .T h ef l u o r e s -
cence of 100 μl of re-suspended cells was measured
using a TECAN GENios Plus spectrofluorimeter. The
cell density was determined by measuring the optical
density at 600 nm (OD600)o f1 0 0μl of re-suspended
cells diluted 10 times with PBS, using the same spec-
trofluorimeter. The results were expressed as the fluor-
escence to OD600 ratio.
Protein expression and purification
T7pRos cells were extemporaneously co-transformed by
heat-shock with the following pairs of constructs:
pMRBAD-XD-CGFP and either pNGG-NTAIL (positive
control N) or pNGG-Stop-NTAIL (negative control S) or
pNGG-NTAIL constructs bearing the mutated NTAIL
sequences of interest (clones 1-4); pMRBAD-Z-CGFP
and pET11a-Z-NGFP (positive fluorescence control Z).
In all cases, transformants were selected on AKCplates.
TBAKC (4 ml per well in a 24-well deep-well plate) was
seeded with a single colony from AKCplates, and then
incubated overnight at 37°C under shaking. The next
day, 4 ml of TBAKC in 24-well deep-well plate were
seeded with 200 μl of the overnight culture and shaken
at 37°C at 200 rpm until the medium became turbid
( f r o m~ 0 . 5t o~ 1O D 600). IPTG and arabinose were
added at final concentrations of 0.5 mM and 2%, respec-
tively, and the cultures were incubated overnight at 17°C
under 200 rpm agitation. Cells were then recovered by
spinning the deep-well plate for 5 min at 3000 g. Each
cell pellet was re-suspended in 1 ml of 50 mM Tris/HCl
pH 8, 0.3 M NaCl, 0.1% Triton X100, 1 mM EDTA, 10
mM imidazole, 1 mM PMSF and 0.25 mg/ml lysozyme
and frozen. After thawing, DNAseI and MgSO4 were
added at final concentrations of 10 μg/ml and 20 mM,
respectively and incubated at 37°C in a shaking incuba-
tor for 30 min. The deep-well plate was spun for 10
min at 3,000 g at 4°C. The supernatant (soluble fraction)
was transferred to 1.5 ml microtubes and supplemented
with 50 μl of a 50% (volume/volume) suspension of
IMAC sepharose high performance (GE healthcare). The
mixture was rotated for one hour on a wheel at 4°C.
Sepharose beads were then washed three times with 1
ml of 50 mM Tris/HCl pH 8, 0.3 M NaCl, 50 mM imi-
dazole, and bound His-tagged proteins were eluted with
100 μlo f5 0m MT r i s / H C lp H8 ,0 . 3MN a C l ,5 0 0m M
imidazole. When purifying His-tagged proteins under
denaturing conditions, the soluble and insoluble frac-
tions were not separated by centrifugation after DNAseI
treatment but the total lysate was directly supplemented
with two volumes of 50 mM Tris/HCl pH 8, 8 M guani-
dinium chloride, 0.3 M NaCl, 10 mM imidazole, and
with 100 μl of a 50% (volume/volume) suspension of
IMAC sepharose beads. Subsequent steps were carried
out as described for the non denaturing conditions,
except that the experiment was performed at room tem-
perature, and that washing and elution buffers were sup-
plemented with 8 M urea. In all cases, eluted proteins
were analyzed by SDS-PAGE.
Additional material
Additional file 1: Figure S1. Recombination region of the pDONR201
®®
plasmid after BP reaction.
Additional file 2: Figure S2. Attempts to increase the mutation rate
above 1%.
Additional file 3: Text S1. Nucleotide sequence of the coding
sequences (S, N, 1-4) used in the experiments reported in Figure 4A and
4B.
Additional file 4: Table S1. This table compares the experimental
conditions of experiment I, II and III reported in Figure 4C.
Additional file 5: Figure S3. Optimization of co-expression conditions.
Abbreviations
Aa: Amino-acid; ACplates: LB agar 100 mm plates containing 100 μg/ml
ampicillin and 34 μg/ml chloramphenicol; AKCplates: LB agar 100 mm plates
containing 100 μg/ml ampicillin 34 μg/ml chloramphenicol and 50 μg/ml
kanamycin; IPTG: Isopropyl β-D-1-thiogalactopyranoside; SDS-PAGE: Sodium
dodecyl sulfate-polyacrylamide gel electrophoresis; TB: Turbo broth.
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